A recent study, incorporating both in vitro and in vivo experiments, reported that the CDK1-SRC interaction-driven transcriptional activation of HSP90AB1 enhances antitumor immunity in HCC [34]. Here, CDK1 is linked to hepatocellular carcinoma.